PROK
PROKIDNEY CORP.
NASDAQ · Healthcare · Biotechnology · US
$1.91
+6.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 408.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.45x
- Price / sales
- 487.84x
- Price / cash flow
- -2.83x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 1622.71x
- EV / EBITDA
- -8.26x
- EV / EBIT
- -7.49x
- Market cap
- $399.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026